心血管安全-话题@MedSci

#心血管安全#

33篇内容 | 778人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2078566, encodeId=d3c420e85661e, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=格列美脲心血管安全性机制与相关研究探讨, objectType=article, longId=739251, objectId=cf4fe39251d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf4fe39251d0, replyNumber=0, likeNumber=30, createdTime=2022-09-26, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf4fe39251d0, moduleTitle=格列美脲心血管安全性机制与相关研究探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf4fe39251d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078564, encodeId=f59020e8564cb, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=DVDR:格列美脲的心血管安全性, objectType=article, longId=733166, objectId=9d38e3316601, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d38e3316601, replyNumber=0, likeNumber=38, createdTime=2022-10-16, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d38e3316601, moduleTitle=DVDR:格列美脲的心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d38e3316601)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078563, encodeId=dfdc20e856376, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？, objectType=article, longId=218896, objectId=fc4b218896c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4b218896c7, replyNumber=0, likeNumber=29, createdTime=2022-09-06, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4b218896c7, moduleTitle=Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4b218896c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078565, encodeId=d39320e856574, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=如何选择心血管安全性良好的降糖药物, objectType=article, longId=737613, objectId=5b9ee3761358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9ee3761358, replyNumber=0, likeNumber=27, createdTime=2022-12-25, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9ee3761358, moduleTitle=如何选择心血管安全性良好的降糖药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9ee3761358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078562, encodeId=008a20e85625a, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Lancet：非布索坦vs别嘌呤醇用于高尿酸长期治疗的心血管安全性评估研究, objectType=article, longId=203245, objectId=8d0520324552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d0520324552, replyNumber=0, likeNumber=40, createdTime=2021-04-22, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d0520324552, moduleTitle=Lancet：非布索坦vs别嘌呤醇用于高尿酸长期治疗的心血管安全性评估研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d0520324552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078561, encodeId=0dff20e856114, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性, objectType=article, longId=198545, objectId=0a21198545d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a21198545d5, replyNumber=0, likeNumber=30, createdTime=2021-03-18, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a21198545d5, moduleTitle=Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a21198545d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078557, encodeId=ebd120e855762, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=罗沙司他全球III期临床研究证实其心血管安全性, objectType=article, longId=166305, objectId=121416630562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121416630562, replyNumber=0, likeNumber=30, createdTime=2020-03-15, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121416630562, moduleTitle=罗沙司他全球III期临床研究证实其心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121416630562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078560, encodeId=151c20e856087, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Eur Respir J：尼达尼布的心血管安全性, objectType=article, longId=180635, objectId=b2f818063507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2f818063507, replyNumber=0, likeNumber=38, createdTime=2020-04-17, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2f818063507, moduleTitle=Eur Respir J：尼达尼布的心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2f818063507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078559, encodeId=edb420e855902, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=2019年ADA：口服semaglutide治疗2型糖尿病的心血管安全性可控, objectType=article, longId=168239, objectId=cddc168239ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cddc168239ad, replyNumber=0, likeNumber=31, createdTime=2019-09-30, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cddc168239ad, moduleTitle=2019年ADA：口服semaglutide治疗2型糖尿病的心血管安全性可控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cddc168239ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078556, encodeId=0ce620e8556d4, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=全球III期临床研究：roxadustat的心血管安全性得到证实, objectType=article, longId=165928, objectId=8d7416592893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d7416592893, replyNumber=0, likeNumber=40, createdTime=2020-03-23, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d7416592893, moduleTitle=全球III期临床研究：roxadustat的心血管安全性得到证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d7416592893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078555, encodeId=f66820e855597, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=JAMA：阿地溴铵长期心血管安全性研究, objectType=article, longId=165818, objectId=da9a165818b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da9a165818b7, replyNumber=0, likeNumber=31, createdTime=2019-11-30, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da9a165818b7, moduleTitle=JAMA：阿地溴铵长期心血管安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da9a165818b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078551, encodeId=56bc20e855182, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Cardiovasc Diabetol：抗糖尿病药物排排坐哪种心血管安全性**？, objectType=article, longId=145588, objectId=03e614558804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e614558804, replyNumber=0, likeNumber=37, createdTime=2019-04-27, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e614558804, moduleTitle=Cardiovasc Diabetol：抗糖尿病药物排排坐哪种心血管安全性**？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e614558804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078558, encodeId=6fc320e85580b, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=罗沙司他心血管安全性获权威数据验证，百亿美元EPO市场受冲击！, objectType=article, longId=167077, objectId=d6c016e0776f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6c016e0776f, replyNumber=0, likeNumber=28, createdTime=2019-08-30, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6c016e0776f, moduleTitle=罗沙司他心血管安全性获权威数据验证，百亿美元EPO市场受冲击！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6c016e0776f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078554, encodeId=13ee20e855406, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者口服司美鲁肽的心血管安全性, objectType=article, longId=150385, objectId=8bec15038557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bec15038557, replyNumber=0, likeNumber=29, createdTime=2019-06-03, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bec15038557, moduleTitle=Diabetes Obes Metab：2型糖尿病患者口服司美鲁肽的心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bec15038557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078552, encodeId=3b4620e8552ad, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=Circulation：痛风患者使用别嘌呤醇与非布索坦的心血管安全性相似, objectType=article, longId=146264, objectId=2229146264b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2229146264b2, replyNumber=0, likeNumber=37, createdTime=2019-01-20, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2229146264b2, moduleTitle=Circulation：痛风患者使用别嘌呤醇与非布索坦的心血管安全性相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2229146264b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078550, encodeId=d51020e8550cf, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=三种戒烟药物的心血管安全性排排坐, objectType=article, longId=139724, objectId=0159139e248d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0159139e248d, replyNumber=0, likeNumber=34, createdTime=2019-03-06, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0159139e248d, moduleTitle=三种戒烟药物的心血管安全性排排坐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0159139e248d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078553, encodeId=206820e85535c, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=NEJM：超重或肥胖患者给予氯卡色林治疗的心血管安全性分析, objectType=article, longId=149169, objectId=8c98149169ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c98149169ef, replyNumber=0, likeNumber=31, createdTime=2019-08-16, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c98149169ef, moduleTitle=NEJM：超重或肥胖患者给予氯卡色林治疗的心血管安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c98149169ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078548, encodeId=ad9620e854814, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=NEJM：非布司他或别嘌呤醇对痛风患者的心血管安全性分析！, objectType=article, longId=133763, objectId=f455133e6371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f455133e6371, replyNumber=0, likeNumber=44, createdTime=2018-06-10, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f455133e6371, moduleTitle=NEJM：非布司他或别嘌呤醇对痛风患者的心血管安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f455133e6371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078549, encodeId=dc3020e8549bf, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=JAMA Intern Med：戒烟药物心血管安全性研究, objectType=article, longId=134757, objectId=3327134e57e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3327134e57e9, replyNumber=0, likeNumber=40, createdTime=2018-05-29, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3327134e57e9, moduleTitle=JAMA Intern Med：戒烟药物心血管安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3327134e57e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078547, encodeId=58ce20e85474a, content=<a href='/topic/show?id=6c5951e9161' target=_blank style='color:#2F92EE;'>#心血管安全#</a>, objectTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, objectType=article, longId=127162, objectId=547a12e162f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547a12e162f7, replyNumber=0, likeNumber=42, createdTime=2018-10-14, rootId=0, userName=朱睿睿, userId=a57b78, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547a12e162f7, moduleTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547a12e162f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

心血管安全

2020-05-29

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

格列美脲心血管安全性机制与相关研究探讨

2022-09-26

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

DVDR:格列美脲的心血管安全性

2022-10-16

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？

2022-09-06

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

如何选择心血管安全性良好的降糖药物

2022-12-25

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Lancet：非布索坦vs别嘌呤醇用于高尿酸长期治疗的心血管安全性评估研究

2021-04-22

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性

2021-03-18

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

罗沙司他全球III期临床研究证实其心血管安全性

2020-03-15

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Eur Respir J：尼达尼布的心血管安全性

2020-04-17

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

2019年ADA：口服semaglutide治疗2型糖尿病的心血管安全性可控

2019-09-30

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

全球III期临床研究：roxadustat的心血管安全性得到证实

2020-03-23

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

JAMA：阿地溴铵长期心血管安全性研究

2019-11-30

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Cardiovasc Diabetol：抗糖尿病药物排排坐哪种心血管安全性**？

2019-04-27

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

罗沙司他心血管安全性获权威数据验证，百亿美元EPO市场受冲击！

2019-08-30

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Diabetes Obes Metab：2型糖尿病患者口服司美鲁肽的心血管安全性

2019-06-03

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

Circulation：痛风患者使用别嘌呤醇与非布索坦的心血管安全性相似

2019-01-20

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

三种戒烟药物的心血管安全性排排坐

2019-03-06

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

NEJM：超重或肥胖患者给予氯卡色林治疗的心血管安全性分析

2019-08-16

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

NEJM：非布司他或别嘌呤醇对痛风患者的心血管安全性分析！

2018-06-10

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

JAMA Intern Med：戒烟药物心血管安全性研究

2018-05-29

朱睿睿 (审核中...)

前往app查看评论内容

#心血管安全#

JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！

2018-10-14

科室
- - 订阅+
  - 更多科室
工具
服务